Nigerian biotech startup becomes first African lab to offer liquid biopsy to advance cancer diagnosis

A Nigerian biotech startup called Syndicate Bio has teamed up with SophiaGenetics, a company specializing in advanced medical software, to bring state-of-the-art genomic testing to Africa for the first time.

This partnership is a big deal for healthcare in Africa because it means people across the continent will have access to cutting-edge genetic technology that wasn’t available before.

With Sophia Genetics’ cloud-based healthcare solutions, Syndicate Bio wants to make genetic testing more accessible and give healthcare providers better tools for diagnosing diseases. This is especially important because Africa has a high number of cancer cases, with many people not getting the care they need. Without immediate action, the number of cancer-related deaths in Africa is expected to rise significantly by 2030.